| Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center. | |
| | |
MedLine Citation:
|
PMID: 23359006 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OBJECTIVE: To assess the efficacy of epoprostenol treatment in Japanese patients with pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD). METHODS: Sixteen patients with PAH-CTD treated with continuous intravenous epoprostenol at a single center between 2000 and 2009 were enrolled. Baseline characteristics, short-term and long-term outcomes, predictors of mortality, and safety profiles were evaluated. For survival analysis, 16 controls were selected who matched the underlying CTD, World Health Organization functional class, and use of PAH drugs, except for epoprostenol. RESULTS: Six patients had systemic lupus erythematosus, five had mixed CTD, four had systemic sclerosis, and one had primary Sjögren's syndrome. The mean pulmonary arterial pressure (mPAP), cardiac index (CI), pulmonary vascular resistance, and functional class were significantly improved during the first 6 months of epoprostenol treatment. Cumulative survival rates at 1, 2, and 3 years in epoprostenol-treated patients were 69, 69, and 55 %, respectively, and were significantly better than those of the controls. Functional class, CI at baseline, and reduction of mPAP at 6 months were identified as predictors of survival. Adverse events, including flushing and catheter-related infection, were frequent, but all patients tolerated the treatment. CONCLUSION: Based on the improvements in both short-term and long-term outcomes among our patient cohort, epoprostenol is an effective treatment for CTD patients with advanced PAH. |
| | |
Authors:
|
Yuichiro Shirai; Hidekata Yasuoka; Tsutomu Takeuchi; Toru Satoh; Masataka Kuwana |
Related Documents
:
|
3605986 - The treatment of amputation neuromas in fingers with a centrocentral nerve union. 16996006 - Neuronavigator-guided percutaneous radiofrequency thermocoagulation in the treatment of... 23306756 - Testing the effectiveness of intravitreal ranibizumab during 12 months of follow-up in ... 23149126 - Variants in the vegfa gene and treatment outcome after anti-vegf treatment for neovascu... 1959266 - Unicompartmental prosthesis for gonarthrosis. a nine-year series of 575 knees from a sw... 20003606 - Vestibular schwannoma: role of conservative management. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-1-29 |
Journal Detail:
|
Title: Modern rheumatology / the Japan Rheumatism Association Volume: - ISSN: 1439-7609 ISO Abbreviation: Mod Rheumatol Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-1-29 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100959226 Medline TA: Mod Rheumatol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Molecular mechanisms of central leptin resistance in obesity.
Next Document: Young male patient diagnosed with cutaneous polyarteritis nodosa successfully treated with etanercep...